 Connection
Nickolas Zaller to Substance Abuse, Intravenous
This is a "connection" page, showing publications Nickolas Zaller has written about Substance Abuse, Intravenous.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
5.907 |
|
|
|
-
Ostrach B, Buer LM, Armbruster S, Brown H, Yochym G, Zaller N. COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains. J Rural Health. 2021 01; 37(1):252-255.
Score: 0.736
-
Zaller N, Ostrach B. HCV, injection drug use, and the importance of harm reduction in Kenya. Lancet Infect Dis. 2019 11; 19(11):1158-1159.
Score: 0.694
-
Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T. Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care. Int J Drug Policy. 2015 Jan; 26(1):37-42.
Score: 0.491
-
Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013 Jun; 48(8):590-9.
Score: 0.449
-
Zaller ND, Yokell MA, Nayak SM, Fu JJ, Bazazi AR, Rich JD. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island. J Urban Health. 2012 Aug; 89(4):659-70.
Score: 0.423
-
Zaller ND, Yokell MA, Apeakorang N, Gaggin J, Case P. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. J Health Care Poor Underserved. 2012 Aug; 23(3):1310-26.
Score: 0.423
-
Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011 Sep; 5(3):175-80.
Score: 0.397
-
Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. J Urban Health. 2010 Dec; 87(6):942-53.
Score: 0.377
-
Zaller ND, Yokell MA, Jeronimo A, Bratberg JP, Case P, Rich JD. Adverse event associated with a change in nonprescription syringe sale policy. J Am Pharm Assoc (2003). 2010 Sep-Oct; 50(5):619-22.
Score: 0.371
-
Zaller ND, Bazazi AR, Velazquez L, Rich JD. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 2009 02; 6(2):787-97.
Score: 0.334
-
Zaller ND, Thurmond P, Brett J, Carleton JC, Rich JD. Linkage to methadone treatment from acute opiate detoxification treatment. J Opioid Manag. 2006 Nov-Dec; 2(6):341-6.
Score: 0.284
-
Meteliuk A, Prokhorova T, Filippovych S, Ompad DC, Zaller N. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data. Drug Alcohol Depend. 2020 11 01; 216:108216.
Score: 0.185
-
Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013 Oct; 17 Suppl 2:S118-27.
Score: 0.115
-
Nunn A, Zaller N, Dickman S, Nijhawan A, Rich JD. Improving access to opiate addiction treatment for prisoners. Addiction. 2010 Jul; 105(7):1312-3.
Score: 0.092
-
Mitty JA, Bazerman LB, Selwyn K, Beckwith CG, Zaller ND, Rich JD. Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read. 2008 Dec; 18(12):596-600.
Score: 0.082
-
Beckwith CG, Zaller N, Flanigan TP. HIV counseling and testing among injection drug users needs to continue. Am J Public Health. 2007 Jul; 97(7):1161.
Score: 0.074
-
Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):292-7.
Score: 0.073
-
Brim N, Zaller N, Taylor LE, Feller E. Twinrix vaccination schedules among injecting drug users. Expert Opin Biol Ther. 2007 Mar; 7(3):379-89.
Score: 0.073
-
Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. A success story: HIV prevention for injection drug users in Rhode Island. Subst Abuse Treat Prev Policy. 2006 Dec 04; 1:34.
Score: 0.072
-
Zaller N, Nelson KE, Aladashvili M, Badridze N, del Rio C, Tsertsvadze T. Risk factors for hepatitis C virus infection among blood donors in Georgia. Eur J Epidemiol. 2004; 19(6):547-53.
Score: 0.058
-
Brinkley-Rubinstein L, Crowley C, Montgomery MC, Peterson M, Zaller N, Martin R, Clarke J, Dubey M, Chan PA. Interest and Knowledge of HIV Pre-Exposure Prophylaxis in a Unified Jail and Prison Setting. J Correct Health Care. 2020 01; 26(1):36-41.
Score: 0.045
-
Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018 03 01; 184:57-63.
Score: 0.039
-
Wakeman SE, Zaller ND, Flanigan TP, Pinkston M, Montague BT, Rich JD. HIV among marginalized populations in Rhode Island. Med Health R I. 2009 Jul; 92(7):244-6.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|